CANCER, A LEADING CAUSE OF MORTALITY WORLDWIDE
That cancer is a leading killer worldwide is beyond a doubt: according to the World Health Organization (WHO), in 2012 there were roughly 14.0 million new cases. Cancer is the second leading cause of death globally, and was responsible for 8.8 million deaths in 20151. More worrying yet is the number of new cases is expected to rise by about 70% over the next two decades.
Early detection is crucial to reducing cancer mortality. This involves early diagnosis of signs and symptoms, plus screening to identify individuals with abnormalities. In addition to this, effective treatment, including pain relief and palliative care, can help increase cancer survival rates and reduce patient suffering.
One of the reasons cancer is so difficult to cure is it is not just one disease. The WHO estimates there are more than 100 different kinds of cancer2, and each one is specific and requires an adapted treatment.
Recent research has shown that two patients suffering from the same type of cancer can respond differently to the same treatment. This means personalized medicine can be particularly effective in the fight against cancer, offering each patient an individualized treatment tailored to their tumor.
OUR WAY OF RISING TO THE CHALLENGE
Our open model of innovation, which focuses on scientific partnership, has helped us develop new approaches and expertise to devise targeted treatments that are effective in beating back cancer.
Being open to scientific partnerships is absolutely essential for Sanofi. By working with academic research teams, biotech companies and specialized cancer centers, Sanofi plays an active role in fostering innovation in treating cancer.
References:1 WHO, http://www.who.int/mediacentre/factsheets/fs297/en/
2 WHO, http://www.who.int/cancer/en/
3 As of February 9th 2016